1 / 6

Bi-Specific MAbS Market Global Report 2020-30: Covid 19 Impact and Recovery

The major players covered in the global bi-specific MAbs market are Johnson & Johnson, Novartis AG, Hoffmann-La Roche Ltd., Novo Nordisk A/S, Bayer AG, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb.

ramtbrc
Télécharger la présentation

Bi-Specific MAbS Market Global Report 2020-30: Covid 19 Impact and Recovery

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bi-Specific MAbS Market Global Report 2020-30: Covid 19 Growth And Change © The Business Research Company. All rights reserved.

  2. Bi-Specific MAbS Market Characteristics: Click Here To View Complete Report The global bi-specific MAbs market was valued at about $1.56 billion in 2019 and is expected to grow to $2.93 billion in 2020 at a compound annual growth rate (CAGR) of 87.6%. The COVID-19 restrictions caused a slowdown in growth from 2018 due to missed patient visits affecting potential new patients who deferred the care, whereas existing patients remained on their treatment. However, with the sales beginning to recover slowly, the market is expected to stabilize and reach $6.12 billion by 2023 at a CAGR of 27.8%. The Business Research Company published its Bi-Specific MAbS Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Bi-Specific MAbS market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus. The report covers the Bi-Specific MAbS market’s segments- 1) By Type: Catumaxomab (Removab), Blinatumomab, Duligotumab, SAR 156597 2) By Product Type: In Vivo, In Vitro The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. © The Business Research Company. All rights reserved.

  3. Major Key Players:Johnson & Johnson, Novartis AG, Hoffmann-La Roche Ltd., Novo Nordisk A/S, Bayer AG, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Click Here To Get A Sample Report © The Business Research Company. All rights reserved.

  4. Table Of Content 1. Executive Summary 2. Report Structure 3. Bi-Specific MAbS Market Characteristics 4. Bi-Specific MAbS Market Product Analysis 5. Bi-Specific MAbS Market Supply Chain …… 26. Key Mergers And Acquisitions In The Bi-Specific MAbS Market 27. Bi-Specific MAbS Market Trends And Strategies 28. Bi-Specific MAbS Market Future Outlook and Potential Analysis 29. Appendix Click Here To Get A Sample Report The Business Research Company. All rights reserved.

  5. Get In Touch Whatever your need be, at The Business Research Company we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. © The Business Research Company. All rights reserved.

  6. Americas The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info Asia The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info © The Business Research Company. All rights reserved.

More Related